21 types of health apps the FDA could regulate but won’t (MobiHealthNews):
“The FDA final guidance finally published last week and it included very few surprises. One new section in the final guidelines — that was not included in the draft guidance — is a list of the types of apps that the FDA says will fall under its enforcement discretion. That means that these apps may meet the definition of a medical device, but Read the rest of this entry »
Over 30 speakers and 170 registered participants discussed the latest on brain research, health and innovation at the fourth annual SharpBrains Virtual Summit, held in September 2013. Here are some of the fascinating highlights* that can help identify emerging opportunities and prepare for significant changes likely to occur in the next 3–5 years.
What surprised/ impressed us the most (in brackets, the Speaker who prompted the highlight):
- How the Human Brain Project is building a comprehensive brain simulation web portal for hundreds of neuroscientists to find principles that can not only optimize brain health but also computing, manufacturing and IT networks. (Sean Hill)
- How different Brain Health will look in 2020. i.e. we may well see a “self-administered annual brain health check-up” (Alvaro Fernandez) building on current tablet-based cognitive baseline tests. (Joan Severson)
- Two billion people worldwide suffer from brain based health and productivity challenges, and many could benefit from evidence-based interventions delivered over the web via computers/ mobile. (Alvaro Fernandez)
- The increasing role positive psychology is playing in leadership and wellness initiatives of large organizations. Many companies are using meditation programs at work, helping place the human brain at the center of the human resources equation. (Hyong Un)
- How health providers can expand focus to include emotional and cognitive health. Kaiser Permanente’s simple and powerful posters are beautiful and inspiring. (Alexandra Morehouse) Read the rest of this entry »
Time for SharpBrains’ July 2013 e-newsletter, featuring a variety of resources and articles at the frontier of applied neuroplasticity and brain fitness. Enjoy the brain food!
Finally, please make sure to review the impressive Speaker Roster at the upcoming 2013 SharpBrains Virtual Summit (Sept 19–20, held over the Internet so there is no need to travel). We hope you can join us!
Have a great summer.
First ADHD brain wave test approved by FDA (CBS News):
“Diagnosing someone with attention deficit hyperactivity disorder (ADHD) is often a tricky science because it relies heavily on psychiatric and behavioral examinations. For the first time, the Food and Drug Administration has approved a device that Read the rest of this entry »
Drugs for Early-Stage Alzheimer’s (good New York Times editorial):
“The Food and Drug Administration has proposed lowering the bar for approving drugs to treat people at the earliest stages of Alzheimer’s disease, before they have developed any serious impairment or overt dementia. The goal is commendable — to find ways to prevent or slow the progression of this terrible disease before it can rob people of their mental capacities. But the proposal raises troubling questions as to whether the agency would end up approving drugs that provide little or no clinical benefit yet Read the rest of this entry »
By: Alvaro Fernandez
Here you are several recent articles quoting SharpBrains and our new Digital Brain Health market report –which I’ll discuss today at ESCoNS2:
Just a quick note: we’ll host a webinar on January 30th to discuss key market predictions based on “The Digital Brain Health Market 2012–2020: Web-based, mobile and biometrics-based technology to assess, monitor and enhance cognition and brain functioning”, our new market report.
Here are 10 predictions, many of which will likely be realized before the end of 2013: Read the rest of this entry »